Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal vs IV Methylprednisolone for MS Relapses
NCT06223074Phase 2Enrolling by invitation
- Sponsor
- Universidad Nacional Autónoma de México
- Start
- Jan 2023
- Primary completion
- Feb 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone in multiple sclerosis (MS), sponsored by Universidad Nacional Autónoma de México. Started Jan 2023; status: enrolling by invitation.
02
Drugs
methylprednisolone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT06223074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06223074.